vs
AMPCO PITTSBURGH CORP（AP）与IOVANCE BIOTHERAPEUTICS, INC.（IOVA）财务数据对比。点击上方公司名可切换其他公司
AMPCO PITTSBURGH CORP的季度营收约是IOVANCE BIOTHERAPEUTICS, INC.的1.2倍（$104.4M vs $86.8M），IOVANCE BIOTHERAPEUTICS, INC.同比增速更快（17.7% vs 11.5%），AMPCO PITTSBURGH CORP自由现金流更多（$-64.0K vs $-61.9M），过去两年IOVANCE BIOTHERAPEUTICS, INC.的营收复合增速更高（1001.6% vs -2.6%）
安普科匹兹堡公司是一家特种钢材制造商，总部位于宾夕法尼亚州匹兹堡市中心，1929年由多家此前已成立的小型钢铁企业合并组建而成。需要注意区分它和其他同样带有Ampco名称的企业，比如位于密尔沃基的铜基合金生产商、迈阿密的橱柜企业等。
艾欧万斯生物治疗公司是一家总部位于加利福尼亚州圣卡洛斯的生物制药初创企业，专注于开发针对癌症的肿瘤浸润淋巴细胞（TIL）疗法，致力于为癌症患者提供创新型的免疫治疗方案。
AP vs IOVA — 直观对比
营收规模更大
AP
是对方的1.2倍
$86.8M
营收增速更快
IOVA
高出6.3%
11.5%
自由现金流更多
AP
多$61.8M
$-61.9M
两年增速更快
IOVA
近两年复合增速
-2.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $104.4M | $86.8M |
| 净利润 | $-57.7M | — |
| 毛利率 | — | 67.4% |
| 营业利润率 | -54.0% | -84.7% |
| 净利率 | -55.2% | — |
| 营收同比 | 11.5% | 17.7% |
| 净利润同比 | -1958.9% | — |
| 每股收益（稀释后） | $-2.87 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收APIOVA
| Q4 25 | $104.4M | $86.8M | ||
| Q3 25 | $103.7M | $67.5M | ||
| Q2 25 | $108.9M | $60.0M | ||
| Q1 25 | $99.2M | $49.3M | ||
| Q4 24 | $93.6M | $73.7M | ||
| Q3 24 | $92.1M | $58.6M | ||
| Q2 24 | $107.1M | $31.1M | ||
| Q1 24 | $110.0M | $715.0K |
净利润APIOVA
| Q4 25 | $-57.7M | — | ||
| Q3 25 | $-2.2M | $-91.3M | ||
| Q2 25 | $-7.3M | $-111.7M | ||
| Q1 25 | $1.1M | $-116.2M | ||
| Q4 24 | $3.1M | — | ||
| Q3 24 | $-2.0M | $-83.5M | ||
| Q2 24 | $2.0M | $-97.1M | ||
| Q1 24 | $-2.7M | $-113.0M |
毛利率APIOVA
| Q4 25 | — | 67.4% | ||
| Q3 25 | — | 43.0% | ||
| Q2 25 | — | 5.5% | ||
| Q1 25 | — | -0.8% | ||
| Q4 24 | — | 68.7% | ||
| Q3 24 | — | 46.2% | ||
| Q2 24 | — | -0.8% | ||
| Q1 24 | — | — |
营业利润率APIOVA
| Q4 25 | -54.0% | -84.7% | ||
| Q3 25 | 1.1% | -140.7% | ||
| Q2 25 | -2.8% | -189.8% | ||
| Q1 25 | 3.9% | -245.8% | ||
| Q4 24 | 5.5% | -117.5% | ||
| Q3 24 | 2.0% | -152.1% | ||
| Q2 24 | 4.7% | -327.6% | ||
| Q1 24 | 0.1% | -16464.6% |
净利率APIOVA
| Q4 25 | -55.2% | — | ||
| Q3 25 | -2.1% | -135.3% | ||
| Q2 25 | -6.7% | -186.2% | ||
| Q1 25 | 1.2% | -235.5% | ||
| Q4 24 | 3.3% | — | ||
| Q3 24 | -2.1% | -142.7% | ||
| Q2 24 | 1.9% | -312.2% | ||
| Q1 24 | -2.5% | -15800.8% |
每股收益（稀释后）APIOVA
| Q4 25 | $-2.87 | — | ||
| Q3 25 | $-0.11 | — | ||
| Q2 25 | $-0.36 | $-0.33 | ||
| Q1 25 | $0.06 | $-0.36 | ||
| Q4 24 | $0.16 | $-0.24 | ||
| Q3 24 | $-0.10 | $-0.28 | ||
| Q2 24 | $0.10 | $-0.34 | ||
| Q1 24 | $-0.14 | $-0.42 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $10.7M | $297.0M |
| 总债务越低越好 | $117.9M | — |
| 股东权益账面价值 | $32.6M | $698.6M |
| 总资产 | $495.4M | $913.2M |
| 负债/权益比越低杠杆越低 | 3.61× | — |
8季度趋势，按日历期对齐
现金及短期投资APIOVA
| Q4 25 | $10.7M | $297.0M | ||
| Q3 25 | $15.0M | $300.8M | ||
| Q2 25 | $9.9M | $301.2M | ||
| Q1 25 | $7.1M | $359.7M | ||
| Q4 24 | $15.4M | $323.8M | ||
| Q3 24 | $11.8M | $397.5M | ||
| Q2 24 | $7.9M | $412.5M | ||
| Q1 24 | $10.8M | $356.2M |
总债务APIOVA
| Q4 25 | $117.9M | — | ||
| Q3 25 | $119.0M | — | ||
| Q2 25 | $115.9M | — | ||
| Q1 25 | $115.0M | — | ||
| Q4 24 | $116.4M | — | ||
| Q3 24 | $116.0M | — | ||
| Q2 24 | $119.4M | — | ||
| Q1 24 | $116.2M | — |
股东权益APIOVA
| Q4 25 | $32.6M | $698.6M | ||
| Q3 25 | $60.1M | $702.3M | ||
| Q2 25 | $62.7M | $698.5M | ||
| Q1 25 | $64.6M | $767.9M | ||
| Q4 24 | $58.9M | $710.4M | ||
| Q3 24 | $61.3M | $773.5M | ||
| Q2 24 | $58.0M | $768.5M | ||
| Q1 24 | $56.3M | $680.0M |
总资产APIOVA
| Q4 25 | $495.4M | $913.2M | ||
| Q3 25 | $524.4M | $904.9M | ||
| Q2 25 | $537.2M | $907.4M | ||
| Q1 25 | $536.2M | $966.7M | ||
| Q4 24 | $530.9M | $910.4M | ||
| Q3 24 | $547.4M | $991.1M | ||
| Q2 24 | $560.8M | $964.3M | ||
| Q1 24 | $565.8M | $869.8M |
负债/权益比APIOVA
| Q4 25 | 3.61× | — | ||
| Q3 25 | 1.98× | — | ||
| Q2 25 | 1.85× | — | ||
| Q1 25 | 1.78× | — | ||
| Q4 24 | 1.98× | — | ||
| Q3 24 | 1.89× | — | ||
| Q2 24 | 2.06× | — | ||
| Q1 24 | 2.06× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $2.7M | $-52.6M |
| 自由现金流经营现金流 - 资本支出 | $-64.0K | $-61.9M |
| 自由现金流率自由现金流/营收 | -0.1% | -71.3% |
| 资本支出强度资本支出/营收 | 2.7% | 10.7% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-8.1M | $-336.2M |
8季度趋势，按日历期对齐
经营现金流APIOVA
| Q4 25 | $2.7M | $-52.6M | ||
| Q3 25 | $6.3M | $-78.7M | ||
| Q2 25 | $-2.3M | $-67.4M | ||
| Q1 25 | $-5.3M | $-103.7M | ||
| Q4 24 | $7.5M | $-73.3M | ||
| Q3 24 | $11.4M | $-59.0M | ||
| Q2 24 | $-5.3M | $-98.4M | ||
| Q1 24 | $4.5M | $-122.3M |
自由现金流APIOVA
| Q4 25 | $-64.0K | $-61.9M | ||
| Q3 25 | $3.3M | $-89.5M | ||
| Q2 25 | $-3.8M | $-74.9M | ||
| Q1 25 | $-7.5M | $-109.9M | ||
| Q4 24 | $3.7M | $-77.5M | ||
| Q3 24 | $8.4M | $-61.3M | ||
| Q2 24 | $-8.0M | $-98.9M | ||
| Q1 24 | $1.7M | $-126.5M |
自由现金流率APIOVA
| Q4 25 | -0.1% | -71.3% | ||
| Q3 25 | 3.2% | -132.7% | ||
| Q2 25 | -3.5% | -124.9% | ||
| Q1 25 | -7.5% | -222.8% | ||
| Q4 24 | 4.0% | -105.1% | ||
| Q3 24 | 9.1% | -104.6% | ||
| Q2 24 | -7.5% | -317.9% | ||
| Q1 24 | 1.5% | -17685.3% |
资本支出强度APIOVA
| Q4 25 | 2.7% | 10.7% | ||
| Q3 25 | 2.9% | 16.1% | ||
| Q2 25 | 1.3% | 12.4% | ||
| Q1 25 | 2.2% | 12.6% | ||
| Q4 24 | 4.0% | 5.7% | ||
| Q3 24 | 3.2% | 3.9% | ||
| Q2 24 | 2.5% | 1.4% | ||
| Q1 24 | 2.6% | 583.4% |
现金转化率APIOVA
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -4.62× | — | ||
| Q4 24 | 2.40× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -2.64× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AP
| Forged And Cast Mill Rolls | $67.0M | 64% |
| Air Handling Systems | $14.3M | 14% |
| Heat Exchange Coils | $13.1M | 13% |
| Centrifugal Pumps | $10.3M | 10% |
| Forged Engineered Products | $4.0M | 4% |
IOVA
| Amtagvi | $64.9M | 75% |
| Proleukin | $21.9M | 25% |
